RxDoctor Payments Data

Gary Mintz

Washington, DCNPI 1225307523

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $308,188 of the $451,004 with a category attached, or 68.3%. Boston Scientific accounts for 74.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $107,051 and has fallen 65.1% since, to $37,310 in 2025.

$451,004in general payments, 2019–2025

Across 127 payments — averaging $3551.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$336K
  • Medtronic$101K
  • Abbott$5K
  • Spectrawave, Inc$4K
  • Gentuity, LLC$3K
  • Philips North America LLC$2K
  • plus $624 from 2 others
$167,391in ownership & investment interests, 2019–2025

Across 3 payments — averaging $55,797 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spectrawave, Inc$167K

What the payments were for

  • Consulting fees$114,30025%
  • Speaking & faculty fees$308,18868%
  • Grants$5000%
  • Travel & lodging$23,8045%
  • Food & beverage$4,2131%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific80$335,685
Medtronic(2 entities)29$100,945
Abbott2$5,057
Spectrawave, Inc8$4,178
Gentuity, LLC4$2,906
Philips North America LLC2$1,611
Terumo Medical Corporation1$500
Penumbra, Inc.1$124

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →